Background

Taihecheng Medical Group is an operator of oncology hospitals and the largest oncology diagnosis and radiotherapy center network in China, as well as an oncology diagnosis and treatment service solution provider. Taihecheng Medical Group was successfully listed on the New York Stock Exchange in 2009.

Job

The Asia-Pacific evaluation team has provided evaluation consulting services for many times, including the acquisition of Fortis Healthcare Singapore Pte. Ltd. and Shanghai Changan Hospital, the consideration sharing, and the company's convertible bonds, employee options, and multiple affiliated hospitals and medical centers. Enterprise value assessment, etc.